Cargando…
Lack of change in glucose metabolism in eszopiclone-treated primary insomnia patients
STUDY OBJECTIVES: Primary insomnia (PI) may increase diabetes risk. We tested the hypothesis that the effects of PI on glucose metabolism could be improved by 2 months of pharmacological treatment. METHODS: Adult men and women meeting clinical criteria for PI were studied (n=20, body mass index 25.1...
Autores principales: | Buxton, Orfeu M, Pavlova, Milena K, O’Connor, Shawn P, Wang, Wei, Winkelman, John W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530064/ https://www.ncbi.nlm.nih.gov/pubmed/28790874 http://dx.doi.org/10.2147/NSS.S130505 |
Ejemplares similares
-
Eszopiclone for late-life insomnia
por: McCrae, Christina S, et al.
Publicado: (2007) -
Eszopiclone: its use in the treatment of insomnia
por: Monti, Jaime M, et al.
Publicado: (2007) -
Eszopiclone versus zopiclone in the treatment of insomnia
por: Pinto, Luciano Ribeiro, et al.
Publicado: (2016) -
Management of insomnia in elderly patients using eszopiclone
por: Kirkwood, Cynthia, et al.
Publicado: (2010) -
Ausgeschlafen mit Eszopiclon
por: Grätzel, Philipp
Publicado: (2023)